World-first gene-editing drug approved for blood disorders

Medical regulators have approved a gene therapy that aims to cure sickle cell disease and beta thalassemia.

Related Keywords

Boston ,Massachusetts ,United States ,France ,Germany ,United Kingdom ,Italy , ,Sickle Cell Society ,Regulatory Agency ,Middle Eastern ,Julian Beach ,Chief Executive ,Sickle Cell Disease ,Red Blood Cells ,Beta Thalassemia ,Blood Disorders ,Gene Therapy ,Blood Transfusion ,Flood Conditions ,Blood Cells ,Haemoglobin ,Blood Vessels ,Uk ,